“Grippin and colleagues analyzed the records of more than 1000 patients who were treated for advanced skin and lung cancer at MD Anderson between 2019 and ’23. People who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy with checkpoint inhibitors lived significantly longer than those who received the same drugs but didn’t get the vaccine. For patients with advanced lung cancer, the median survival rate nearly doubled, rising from 20.6 months to 37.3.”

From Science.